About this trial
CGF membranes will be prepared using a swing-lock centrifuge. A full-thickness mucoperiosteal flap will be elevated in a narrow alveolar ridge. Implants will be inserted. Autologous bone chips will be harvested via bone scraping and used for augmentation, CGF membranes will be placed over the grafted area. Suturing of the mucoperiosteal flap. Radiographic evaluation of the bone density and tissue thickness will be performed by CBCT preoperatively, immediate postoperative and after the procedure by 4 months. Clinical evaluation of the tissue thickness using periodontal probe preoperatively, immediate postoperatively and after the procedure by 4 months
Eligibility criteria
Qualifiers
A medical history that contraindicates oral surgical treatment such as (uncontrolled/untreated diabetes mellitus, immuno-compromised status, radio or chemotherapy of the oral and maxillofacial region, treatment with oral and/or intravenous bisphosphonates).
Presence of active or untreated periodontal disease.
Vertical root fractures involving the buccal aspect.
Tooth /teeth with horizontal fractures below bone level.
Disqualifiers
Presence of active or untreated periodontal disease.
Vertical root fractures involving the buccal aspect.
Tooth /teeth with horizontal fractures below bone level.
Tooth /teeth with external or internal resorption.
Trial design
Treatments tested in this trial
- concentrated growth factor (CGF) Membrane
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.